The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Comparative study of available medical therapy for hypercalcemia of malignancy
Abstract
The relative efficacy of five drugs in the treatment of hypercalcemia of malignancy was assessed in a randomized study. The drugs were oral phosphate, mithramycin, glucocorticoids, indomethacin, and ethane-1-hydroxy-1, 1-diphosphonate (EHDP). No single agent was universally effective. Oral phosphate and mithramycin were the most efficacious, each producing a decrease in serum calcium concentrations in four of five patients, although there were serious disadvantages with the use of each. Glucocorticoids were effective in only two of five patients who received randomized treatment. A further five patients received nonrandomized treatment with glucocorticoids, and only three of these showed response. Indomethacin was effective in only one of five patients to whom it was given, and EHDP was effective also in only one of five patients. The new diphosphonate, 3-amino-1-hydroxypropane-1, 1-diphosphonate (APD) was evaluated in the treatment of hypercalcemia in 13 patients with malignant disease and two with primary hyperparathyroidism. APD caused a significant decrease in serum calcium concentration in nine of 12 patients within 72 hours. These results indicate that there is no currently available pharmacologic agent that is entirely satisfactory in the treatment of hypercalcemia. The most effective agents were mithramycin, oral phosphate, and APD. Glucocorticoids and orally administered EHDP showed limited effectiveness, and indomethacin was ineffective in the majority of patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early studies have demonstrated that when calcitonin was used clinically to inhibit bone resorption in hypercalcemic cancer patients, the effects of calcitonin were lost after a few days, an effect later termed the “escape phenomenon” (158, 219).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [158]
Citations
Cites
Prostaglandins as Mediators of Hypercalcemia Associated with Certain Types of Cancer
Seyberth, H. W., Segre, G. V., Morgan, J. L., Sweetman, B. J., Potts, J. T., & Oates, J. A. (1975) · New England Journal of Medicine · doi:10.1056/nejm197512182932502 · Cited by 459
Tashjian, A. H., Voelkel, E. F., Levine, L., & Goldhaber, P. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.6.1329 · Cited by 376
Russell, R. G. G., Mühlbauer, R. C., Bisaz, S., Williams, D. A., & Fleisch, H. (1970) · Calcified Tissue Research · doi:10.1007/bf02196199 · Cited by 341
An Automated Procedure for the Simultaneous Determination of Calcium and Phosphorus
Kessler, G., & Wolfman, M. (1964) · Clinical Chemistry · doi:10.1093/clinchem/10.8.686 · Cited by 294
Some Problems of Hyperparathyroidism
Dent, C. E. (1962) · BMJ · doi:10.1136/bmj.2.5317.1419 · Cited by 280
TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)
Frijlink, W. B., Bijvoet, O. M., Te Velde, J., & Heynen, G. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91318-7 · Cited by 258
Direct resorption of bone by human breast cancer cells in vitro
EILON, G., & MUNDY, G. R. (1978) · Nature · doi:10.1038/276726a0 · Cited by 235
Self-citationEffect of Calcitonin and Glucocorticoids in Combination on the Hypercalcemia of Malignancy
BINSTOCK, M. L., & MUNDY, G. R. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-2-269 · Cited by 199
Self-citationHypercalcemia and tumor-prostaglandins: The VX2 carcinoma model in the rabbit
Voelkel, E. F., Tashjian, A. H., Franklin, R., Wasserman, E., & Levine, L. (1975) · Metabolism · doi:10.1016/0026-0495(75)90089-x · Cited by 185
Effects of Dichloromethylene Diphosphonate on Skeletal Mobilization of Calcium in Multiple Myeloma
Siris, E. S., Sherman, W. H., Baquiran, D. C., Schlatterer, J. P., Osserman, E. F., & Canfield, R. E. (1980) · New England Journal of Medicine · doi:10.1056/nejm198002073020602 · Cited by 185
Research works printed but not linked: 2
- Kantrowitz, 1975, Clinical and biochemical effects of diphosphonate in Paget's disease of bone (abstr), Arthritis Rheum, 18, 407A
- 1978, Editorial: Management of hypercalcaemic crisis, Lancet, II, 617
Cited by
Metastasis to bone: causes, consequences and therapeutic opportunities
Mundy, G. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc867 · Cited by 2,777
Self-citationGuise, T. A., & Mundy, G. R. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0323 · Cited by 472
Self-citationA systematic review of the role of bisphosphonates in metastatic disease
Ross, J., Saunders, Y., Edmonds, P., Patel, S., Wonderling, D., Normand, C., & Broadley, K. (2004) · Health Technology Assessment · doi:10.3310/hta8040 · Cited by 467
The Hypercalcemia of Cancer: Clinical Implications and Pathogenic Mechanisms
Mundy, G. R., Ibbotson, K. J., D'Souza, S. M., Simpson, E. L., Jacobs, J. W., & Martin, T. J. (1984) · New England Journal of Medicine · doi:10.1056/nejm198406283102607 · Cited by 353
Self-citationSmall, E. J., Smith, M. R., Seaman, J. J., Petrone, S., & Kowalski, M. O. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.147 · Cited by 341
Metadata
- Authors
- Mundy, G. R., Wilkinson, R., & Heath, D. A.
- Corresponding author
- Mundy, Gregory R.
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 1983-03
- Volume
- 74
- Issue
- 3
- Pages
- 421-432
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W2054887634
- Semantic Scholar
- c1a50641a31d6a6d32ee5c0034ba80d3a86c025f
- Cited by
- 163
- References
- 26
- Citations by year
- 2021: 1 · 2020: 1 · 2018: 1 · 2015: 2 · 2013: 1 · 2012: 1
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- The American Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Management of metastatic bone disease
- Keywords
- hypercalcemia of malignancy, hypercalcemia treatment, mithramycin, glucocorticoids, indomethacin, ethane-1-hydroxy-1,1-diphosphonate, bisphosphonates, primary hyperparathyroidism
- MeSH terms
- Pamidronate, Administration, Oral, Adult, Aged, Calcium, Clinical Trials as Topic, Diphosphonates, Female, Glucocorticoids, Humans, Hypercalcemia, Hyperparathyroidism, Indomethacin, Male, Middle Aged, Plicamycin, Neoplasms, Phosphates, Random Allocation, Etidronic Acid, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparative study of available medical therapy for hypercalcemia of malignancy. https://app.cochat.ai/papers/10.1016/0002-9343(83)90961-0
- The paper
- Mundy, G. R., Wilkinson, R., & Heath, D. A. (1983). Comparative study of available medical therapy for hypercalcemia of malignancy. The American Journal of Medicine. https://doi.org/10.1016/0002-9343(83)90961-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.